JP2023089298A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023089298A5 JP2023089298A5 JP2023072157A JP2023072157A JP2023089298A5 JP 2023089298 A5 JP2023089298 A5 JP 2023089298A5 JP 2023072157 A JP2023072157 A JP 2023072157A JP 2023072157 A JP2023072157 A JP 2023072157A JP 2023089298 A5 JP2023089298 A5 JP 2023089298A5
- Authority
- JP
- Japan
- Prior art keywords
- buffer
- affinity resin
- eluting
- nacl
- elution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 20
- 239000011347 resin Substances 0.000 claims 20
- 229920005989 resin Polymers 0.000 claims 20
- 239000000872 buffer Substances 0.000 claims 14
- 239000012149 elution buffer Substances 0.000 claims 11
- 239000011780 sodium chloride Substances 0.000 claims 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- 238000005406 washing Methods 0.000 claims 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 4
- 229960003589 arginine hydrochloride Drugs 0.000 claims 4
- 238000010828 elution Methods 0.000 claims 4
- 229910001629 magnesium chloride Inorganic materials 0.000 claims 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 2
- 150000001450 anions Chemical class 0.000 claims 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 2
- 229920000053 polysorbate 80 Polymers 0.000 claims 2
- 229940068968 polysorbate 80 Drugs 0.000 claims 2
- 239000001632 sodium acetate Substances 0.000 claims 2
- 235000017281 sodium acetate Nutrition 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- 229960003080 taurine Drugs 0.000 claims 2
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 claims 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 241000702421 Dependoparvovirus Species 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762611709P | 2017-12-29 | 2017-12-29 | |
| US62/611,709 | 2017-12-29 | ||
| JP2020536656A JP7299896B2 (ja) | 2017-12-29 | 2018-12-27 | アデノ随伴ウイルス精製方法 |
| PCT/US2018/067627 WO2019133677A1 (en) | 2017-12-29 | 2018-12-27 | Adeno-associated virus purification methods |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020536656A Division JP7299896B2 (ja) | 2017-12-29 | 2018-12-27 | アデノ随伴ウイルス精製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023089298A JP2023089298A (ja) | 2023-06-27 |
| JP2023089298A5 true JP2023089298A5 (cg-RX-API-DMAC7.html) | 2024-01-09 |
| JP7531654B2 JP7531654B2 (ja) | 2024-08-09 |
Family
ID=67064154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020536656A Active JP7299896B2 (ja) | 2017-12-29 | 2018-12-27 | アデノ随伴ウイルス精製方法 |
| JP2023072157A Active JP7531654B2 (ja) | 2017-12-29 | 2023-04-26 | アデノ随伴ウイルス精製方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020536656A Active JP7299896B2 (ja) | 2017-12-29 | 2018-12-27 | アデノ随伴ウイルス精製方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11981934B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3731863A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7299896B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20200106045A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111655285B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018395254B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020013197A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3084827A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL275533B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020006884A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202006232SA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019133677A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020013953A (es) * | 2018-07-11 | 2021-03-09 | Takeda Pharmaceuticals Co | Composiciones de virus adenoasociado (aav). |
| US20220267796A1 (en) * | 2019-06-28 | 2022-08-25 | Takeda Pharmaceutical Company Limited | Adeno-associated virus purification methods |
| EP3868886A1 (en) * | 2020-02-21 | 2021-08-25 | Bia Separations D.O.O. | A method for separation or depletion of empty aav capsids from full aav capsids |
| US20220033782A1 (en) * | 2020-07-29 | 2022-02-03 | Pall Corporation | Adenovirus-associated viruses separation method |
| CN116234619B (zh) * | 2020-08-18 | 2026-07-21 | 赛多利斯比亚分离有限责任公司 | 宿主细胞dna的金属亲和提取 |
| AU2021375404A1 (en) * | 2020-11-03 | 2023-06-08 | Pfizer Inc. | Methods for purification of aav vectors by anion exchange chromatography |
| CN116802308A (zh) * | 2020-11-03 | 2023-09-22 | 辉瑞公司 | 通过阴离子交换色谱法纯化aav载体的方法 |
| JP2023550799A (ja) * | 2020-11-24 | 2023-12-05 | ザルトリウス ビーアイエー セパレーションズ ディー.オー.オー. | アフィニティークロマトグラフィーのための改善された洗浄方法 |
| JP2024503234A (ja) * | 2020-12-23 | 2024-01-25 | ファイザー・インク | 親和性クロマトグラフィーによるaavベクターの精製方法 |
| CA3205744A1 (en) * | 2021-01-21 | 2022-07-28 | Tamara ZEKOVIC | Method for purifying recombinant viral particles |
| CN114591921B (zh) * | 2022-03-31 | 2024-08-02 | 上海勉亦生物科技有限公司 | 腺相关病毒的纯化方法和洗脱液 |
| WO2022222869A1 (zh) * | 2021-04-19 | 2022-10-27 | 信念医药(香港)有限公司 | 重组腺相关病毒及其应用 |
| GB202110014D0 (en) * | 2021-07-12 | 2021-08-25 | Cytiva Bioprocess R & D Ab | A method for separating adeno-associated virus capsids, compositions obtained by said method and uses thereof |
| CN113552349B (zh) * | 2021-07-30 | 2022-07-19 | 上海勉亦生物科技有限公司 | Aav蛋白外壳的检测方法 |
| WO2023077085A2 (en) * | 2021-10-29 | 2023-05-04 | Oxford Biomedica Solutions Llc | Methods and compositions for the purification of adeno-associated virus |
| JP2023098806A (ja) * | 2021-12-29 | 2023-07-11 | 東ソー株式会社 | アデノ随伴ウイルスの精製方法 |
| CN114350622A (zh) * | 2022-01-17 | 2022-04-15 | 苏州博腾生物制药有限公司 | 一种病毒纯化高效保护试剂及其应用 |
| US20250188120A1 (en) | 2022-03-07 | 2025-06-12 | Takeda Pharmaceutical Company Limited | Affinity chromatographic production of clinical human igg products |
| GB202206123D0 (en) * | 2022-04-27 | 2022-06-08 | Cytiva Bioprocess R & D Ab | A pre-screening method and a method for separating adeno-associated virus capsids |
| WO2024233992A2 (en) * | 2023-05-11 | 2024-11-14 | Trophogen, Inc. | Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs |
| KR20260049579A (ko) * | 2023-08-01 | 2026-04-14 | 메르크 파텐트 게엠베하 | 개선된 용리 시스템의 음이온 교환 크로마토그래피를 사용한 aav 입자의 연마 |
| CN122249270A (zh) * | 2023-11-16 | 2026-06-19 | 赛多利斯比亚分离有限责任公司 | 通过采用络合剂递减梯度增强混合物中组分的色谱分离 |
| WO2025207456A1 (en) * | 2024-03-25 | 2025-10-02 | Frontera Therapeutics, Inc. | Methods for purification of adeno associated virus particles by anion exchange chromatography |
| WO2026077794A1 (en) * | 2024-10-07 | 2026-04-16 | Cytiva Us Llc | Plasmid purification methods |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4543363A (en) | 1983-06-15 | 1985-09-24 | Asahi Kasei Kogyo Kabushiki Kaisha | Ion exchanger having hydroxyl groups bonded directly to backbone skeleton |
| SE9902133D0 (sv) | 1999-06-06 | 1999-06-06 | Amersham Pharm Biotech Ab | A method for surface modification, a novel support matrix and the use of the matrix |
| GB9925432D0 (en) * | 1999-10-27 | 1999-12-29 | Univ London | Virus preparation |
| US6593123B1 (en) * | 2000-08-07 | 2003-07-15 | Avigen, Inc. | Large-scale recombinant adeno-associated virus (rAAV) production and purification |
| JP5956331B2 (ja) * | 2009-06-16 | 2016-07-27 | ジェンザイム・コーポレーション | 組換えaavベクターの改良された精製方法 |
| MX379269B (es) * | 2012-10-24 | 2025-03-11 | Genzyme Corp | Elucion de biomoleculas de resinas multimodales utilizando mes y mops como modificadores de fase movil. |
| CN104232687A (zh) * | 2014-09-17 | 2014-12-24 | 许瑞安 | 一种重组腺相关病毒rAAV载体的分离纯化方法 |
| EP3054007A1 (en) * | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step |
| US11015174B2 (en) * | 2015-12-11 | 2021-05-25 | The Trustees Of The University Of Pennsylvania | Scalable purification method for AAV8 |
| EP3387138B2 (en) * | 2015-12-11 | 2026-05-27 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav9 |
| US12564816B2 (en) | 2019-11-21 | 2026-03-03 | Merck Millipore Ltd. | Hydrophilic membranes |
-
2018
- 2018-12-27 IL IL275533A patent/IL275533B2/en unknown
- 2018-12-27 SG SG11202006232SA patent/SG11202006232SA/en unknown
- 2018-12-27 BR BR112020013197A patent/BR112020013197A8/pt not_active Application Discontinuation
- 2018-12-27 JP JP2020536656A patent/JP7299896B2/ja active Active
- 2018-12-27 EP EP18895008.3A patent/EP3731863A4/en not_active Withdrawn
- 2018-12-27 US US16/958,974 patent/US11981934B2/en active Active
- 2018-12-27 CA CA3084827A patent/CA3084827A1/en active Pending
- 2018-12-27 MX MX2020006884A patent/MX2020006884A/es unknown
- 2018-12-27 AU AU2018395254A patent/AU2018395254B2/en active Active
- 2018-12-27 KR KR1020207021627A patent/KR20200106045A/ko active Pending
- 2018-12-27 WO PCT/US2018/067627 patent/WO2019133677A1/en not_active Ceased
- 2018-12-27 CN CN201880087932.0A patent/CN111655285B/zh active Active
-
2023
- 2023-04-26 JP JP2023072157A patent/JP7531654B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021508484A5 (cg-RX-API-DMAC7.html) | ||
| IL275533B2 (en) | Adeno-associated virus purification methods | |
| JPH06316593A (ja) | 蛋白質の精製方法 | |
| JP2013514073A5 (cg-RX-API-DMAC7.html) | ||
| JPH102891A (ja) | 人工的に創製したアフィニティーによるクロマトグラフィー媒体中での溶質の選択的認識 | |
| JP2006523463A5 (cg-RX-API-DMAC7.html) | ||
| CN101720320B (zh) | 使用非功能性聚合树脂提纯羟甲基糠醛的方法 | |
| JP2013511566A5 (cg-RX-API-DMAC7.html) | ||
| JP2024509877A5 (cg-RX-API-DMAC7.html) | ||
| SE526227C2 (sv) | Metod för rening av rekombinant humant serumalbumin | |
| US20080230478A1 (en) | Regeneration Of A Chromatography Matrix | |
| JP7601795B2 (ja) | Glp-1類似体の精製 | |
| WO2019184368A1 (zh) | 一种高纯度rhNGF的制备方法 | |
| Westra et al. | Immobilised metal-ion affinity chromatography purification of histidine-tagged recombinant proteins: a wash step with a low concentration of EDTA | |
| JP2002520338A5 (cg-RX-API-DMAC7.html) | ||
| CN114656551B (zh) | 一种去除双特异性或复杂构型抗体宿主细胞蛋白残留的亲和纯化工艺 | |
| JP2024546855A5 (cg-RX-API-DMAC7.html) | ||
| JP2024518319A5 (cg-RX-API-DMAC7.html) | ||
| KR890001244B1 (ko) | 성장 호르몬-양 물질의 정제방법 | |
| Mahajan et al. | One resin, multiple products: a green approach to purification | |
| JP2003514655A (ja) | 核酸構造を有する化合物を含むサンプル由来の物質の選択的除去方法 | |
| RU2816581C2 (ru) | Очистка аналогов глюкагоноподобного пептида-1 | |
| JP2002536296A (ja) | 血清アルブミンの除去/精製 | |
| JP2007509945A5 (cg-RX-API-DMAC7.html) | ||
| JPS5829079B2 (ja) | セファロスポリン化合物の分離・精製方法 |